Journal
FUTURE ONCOLOGY
Volume 14, Issue 4, Pages 391-407Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2017-0255
Keywords
brain metastasis; breast cancer; chemotherapy; immunotherapy; leptomeningeal disease
Categories
Funding
- Northwestern University Feinberg School of Medicine
Ask authors/readers for more resources
Breast cancer is the most common malignancy among women and accounts for the second highest number of cancer-related deaths. With patients surviving longer due to advances in systemic control, the incidence of CNS involvement is increasing; however, the management of CNS metastases has not undergone parallel advancements. The blood-brain barrier limits the efficacy of most systemic chemotherapies, and the utilization of surgery and radiation beyond first-line therapy is limited. We will explore the recent developments in the medical management of breast cancer brain metastasis. Beyond traditional chemotherapy, we will also discuss targeted therapies and immunotherapies which may provide a survival benefit to this population and thus, offer further treatment options and a path for future research and treatment advances.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available